Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children
- PMID: 16897668
- DOI: 10.1086/505710
Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children
Abstract
Background: The relative invasiveness rates (attack rates) of Streptococcus pneumoniae of different capsular serotypes in children are not known. Estimates of capsular serotype invasiveness (designated "invasive odds ratios") that are based on cross-sectional prevalence carriage data have been published, but these estimates could be biased by variation in the duration of carriage.
Methods: The relative attack rates of invasive pneumococci were measured using national UK surveillance data on invasive pneumococcal disease (IPD) incidence and data on incidence of pneumococcal acquisition from longitudinal studies of nasopharyngeal pneumococcal carriage.
Results: We found significant differences in capsular serotype-specific attack rates. For example, capsular serotypes 4, 14, 7F, 9V, and 18C were associated with rates of >20 IPD cases/100,000 acquisitions, whereas capsular serotypes 23F, 6A, 19F, 16F, 6B, and 15B/C were associated with <10 IPD cases/100,000 acquisitions. There was an inverse relationship between duration of carriage and attack rate by capsular serotype (P<.0001). Attack rates were significantly correlated with invasive odds ratios (P<.0001).
Conclusions: The capsular serotype is a major determinant of both pneumococcal duration of carriage and attack rate. Published invasive odds ratios are a reliable and practical method of determining capsular serotype invasiveness and will be valuable for investigating and characterizing emerging capsular serotypes in the context of conjugate vaccination.
Similar articles
-
Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.J Clin Microbiol. 2011 Apr;49(4):1369-75. doi: 10.1128/JCM.01763-10. Epub 2011 Jan 26. J Clin Microbiol. 2011. PMID: 21270219 Free PMC article.
-
Carriage and invasive isolates of Streptococcus pneumoniae in Caracas, Venezuela: the relative invasiveness of serotypes and vaccine coverage.Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1489-95. doi: 10.1007/s10096-011-1247-5. Epub 2011 Apr 18. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21499972
-
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease.Vaccine. 2010 Dec 16;29(2):283-8. doi: 10.1016/j.vaccine.2010.10.032. Epub 2010 Oct 26. Vaccine. 2010. PMID: 21029807 Free PMC article.
-
Novel pneumococcal serotypes 6C and 6D: anomaly or harbinger.Clin Infect Dis. 2012 Nov 15;55(10):1379-86. doi: 10.1093/cid/cis691. Epub 2012 Aug 16. Clin Infect Dis. 2012. PMID: 22903767 Free PMC article. Review.
-
Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.Int J Infect Dis. 2010 Mar;14(3):e197-209. doi: 10.1016/j.ijid.2009.05.010. Epub 2009 Aug 22. Int J Infect Dis. 2010. PMID: 19700359 Review.
Cited by
-
Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya.J Infect Dis. 2012 Oct 1;206(7):1020-9. doi: 10.1093/infdis/jis447. Epub 2012 Jul 24. J Infect Dis. 2012. PMID: 22829650 Free PMC article.
-
Isolation site influences virulence phenotype of serotype 14 Streptococcus pneumoniae strains belonging to multilocus sequence type 15.Infect Immun. 2015 Dec;83(12):4781-90. doi: 10.1128/IAI.01081-15. Epub 2015 Sep 28. Infect Immun. 2015. PMID: 26416904 Free PMC article.
-
Long Persistence of a Streptococcus pneumoniae 23F Clone in a Cystic Fibrosis Patient.mSphere. 2017 Jun 7;2(3):e00201-17. doi: 10.1128/mSphere.00201-17. eCollection 2017 May-Jun. mSphere. 2017. PMID: 28596991 Free PMC article.
-
Modelling the Epidemiological Impact of Different Adult Pneumococcal Vaccination Strategies in the United Kingdom.Infect Dis Ther. 2025 Mar;14(3):587-602. doi: 10.1007/s40121-025-01111-8. Epub 2025 Feb 11. Infect Dis Ther. 2025. PMID: 39930280 Free PMC article.
-
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study.Vaccine. 2024 Jun 11;42(16):3555-3563. doi: 10.1016/j.vaccine.2024.04.061. Epub 2024 May 3. Vaccine. 2024. PMID: 38704263 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical